Transcatheter closure of an iatrogenic ventricular septal defect after SAPIEN valve implantation

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 3, 2015, Pages E90-E94

  Levi, Daniel S ^a   Salem, Morris ^b   Suh, William ^c  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amplazter; Aortic; TAVR; VSD

Indexed keywords

ADULT; ANGIOGRAPHIC CATHETER; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ARTICLE; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGESTIVE HEART FAILURE; DIZZINESS; DRUG ELUTING STENT; DYSPNEA; EXERCISE TOLERANCE; FAINTNESS; FATIGUE; FEMALE; HEART PALPITATION; HEART VENTRICLE SEPTUM DEFECT; HODGKIN DISEASE; HUMAN; IATROGENIC DISEASE; MIDDLE AGED; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PERCUTANEOUS AORTIC VALVE; PERCUTANEOUS CORONARY INTERVENTION; SAINT JUDE HEART VALVE PROSTHESIS; THORACOTOMY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL VALVULOPLASTY; VASCULAR OCCLUDER; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; CORONARY ANGIOGRAPHY; DEVICES; HEART CATHETERIZATION; HEART INJURIES; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; INJURIES; INTERVENTRICULAR SEPTUM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS DESIGN; SEPTAL OCCLUDER; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CARDIAC CATHETERIZATION; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART INJURIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IATROGENIC DISEASE; MIDDLE AGED; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; SEPTAL OCCLUDER DEVICE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VENTRICULAR SEPTUM;

EID: 84923025603     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25503     Document Type: Article

References (15)

1. Webb JG, Wood DA. Current state of transcatheter aortic valve replacement. J Am Coll Cardiol 2012;60:483-492.
2. Leon MB, Smith CR, Mack M. Transcatheter aortic valve implantation for aortic stenosis in patients that can not undergo surgery. N Engl J Med 2010;363:1597-1607.
3. Mongeon FP, Burkhart HM, Ammash NM, Dearani JA, Li Z, Warnes CA, Connolly HM. Indications and outcomes of surgical closure of ventricular septal defect in adults. JACC Cardiovasc Interv 2010;3:290-297.
4. Roos-Hesslein JW, Meijboom FJ, Spitaels SE, Van Domburg R, Van Rijen EH, Utens EM, Bogers AJ, Simoons ML. Outcomes of patients after surgical closure of ventricular septal defect at a young age: Longitudinal follow-up of 22-34 years. Eur Heart J 2004;25:1057-1062.
5. Thanopoulos B, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the Amplatzer Ventricular Septal Defect Occluder: Initial clinical application in children. J Am Coll Cardiol 1999;33:1395-1399.
6. Fu YC, Bass JL, Amin A, Radtke W, Cheatham JP, Hellenbrand WE, Blazer D, Cao QL, Hijazi ZM. Transcatheter closure of perimembranous VSD using the new Amplatzer Membranous VSD Occluder: Results of the U.S. Phase I Trial. J Am Coll Cardiol 2006;47:319-325.
7. Bass JL, Gruenstein D. Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device. Catheter Cardiovasc Interv 2012;79:1153-1160.
8. Chumgsomprasong P, Durongpisitkul K, Vijarnsorn C, Soongswang J, Lê TP. The results of transcatheter closure of VSD using Amplatzer device and Nit Occlud Lê VSD coil. Catheter Cardiovasc Interv 2011;78:1032-1040.
9. Esteves CA, Solarewicz LA, Cesar R, Neves JR, Esteves V, Arrieta R. Occlusion of the perimembranous VSD using CERA devices. Catheter Cardiovasc Interv 2012;80:182-187.
10. Velasco-Sanchez D, Tzihas A, Ibrahim R. Transcatheter closure of perimembranous ventricular septal defects: Initial human experience with the Amplatzer membranous VSD occluder 2. Catheter Cardiovasc Interv 2012;82:474-479.
11. El Said H, Bratincsak A, Gordon BM, Moore JM. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplatzer Duct Occluder I: Lessons learned and medium term follow up. Catheter Cardiovasc Interv 2012;80:895-903.
12. Vijayalakshmi IB, Narasimhan C, Singh B, Manjunath CN. Treatment of congenital non-ductal shunt lesions with the amplatzer duct occluder II. Catheter Cardiovasc Interv 2013. [Epub ahead of print]
13. Stolt V, Cook S, Raber L. Amplatzer septal occluders to treat iatrogenic cardiac perforations. Catheter Cardiovasc Interv 2012;79:263-270.
14. Gerckens U, Latsios G, Pizzulli L. Percutaneous treatment of a post-TAVI ventricular septal defect: A successful combined procedure for an unusual complication. Catheter Cardiovasc Interv 2012;81:E274-E277.
15. Soufflet V, Van de Bruaene A, Troost E, Gewillig M, Moons P, Post MC, Budts W. Behavior of unrepaired perimembranous ventricular septal defect in young adults. Am J Cardiol 2010;105:404-407.